A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer
Status:
Completed
Trial end date:
2017-02-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the serum testosterone levels in patients with
Metastatic Castration-Resistant Prostate Cancer on SoluMatrix™ Abiraterone Acetate as
Compared to Abiraterone Acetate
Phase:
Phase 2
Details
Lead Sponsor:
Churchill Pharmaceutical LLC Sun Pharma Global FZE